HuGE Literature Finder
Records 1-7
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Cancer 2019 Jan . Sharma Manish R, Joshi Smita S, Karrison Theodore G, Allen Kenisha, Suh Grace, Marsh Robert, Kozloff Mark F, Polite Blase N, Catenacci Daniel V T, Kindler Hedy |
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients.
Scientific reports 2018 May 8 (1): 7359. Belkhir Leïla, Seguin-Devaux Carole, Elens Laure, Pauly Caroline, Gengler Nicolas, Schneider Serge, Ruelle Jean, Haufroid Vincent, Vandercam Berna |
Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture.
Neuro endocrinology letters 2014 35 (2): 123-8. Drobny Michal, Pullmann Rudolf, Odalos Ivan, Skerenova Maria, Saniova Bea |
UGT1A1*28 genotype-driven phase II study of irinotecan and doxifluridine (5'-DFUR, an intermediate form of capecitabine) for metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e14074. Kanekiyo S, Hazama S, Shimizu R, Ozasa H, Yamamoto T, Yoshino S, Okayama N, Hinoda Y, Oka |
Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.
Cancer 2006 Mar 106 (5): 1007-16. Massacesi Cristian, Terrazzino Salvatore, Marcucci Fabiana, Rocchi Marco B, Lippe Paolo, Bisonni Renato, Lombardo Marco, Pilone Alberta, Mattioli Rodolfo, Leon Alber |
Phase I pharmacokinetic (PK) & pharmacogenetic study of sequential infusional irinotecan (IR) and fluorouracil (FU).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Jul 22 (14_suppl): 2075. Grem J L, Wright M, Morrison G, Lin P-X, Leonard G, Nguyen D, Guo X-D, Szabo E, |
Phase I trial of OSI-774 and CPT-11 in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Jul 22 (14_suppl): 3053. Rao R D, Reid J M, Goetz M P, Furth A F, Mandrekar S J, Adjei A A, Ames M M, Safgren S L, Erlichman C, Pitot H |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 27, 2021
- Content source: